|
DRG1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.130800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.900780E-01 |
| Normal-vs-Stage2 |
5.727200E-01 |
| Normal-vs-Stage3 |
3.273700E-02 |
| Normal-vs-Stage4 |
4.037400E-01 |
| Stage1-vs-Stage2 |
7.569200E-01 |
| Stage1-vs-Stage3 |
6.766000E-04 |
| Stage1-vs-Stage4 |
9.394600E-01 |
| Stage2-vs-Stage3 |
3.540300E-02 |
| Stage2-vs-Stage4 |
8.412200E-01 |
| Stage3-vs-Stage4 |
1.287620E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.488600E-01 |
| Normal-vs-AfricanAmerican |
8.427100E-04 |
| Normal-vs-Asian |
5.009800E-01 |
| Caucasian-vs-AfricanAmerican |
2.01420000000008E-05 |
| Caucasian-vs-Asian |
5.178800E-01 |
| AfricanAmerican-vs-Asian |
3.551800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.801200E-01 |
| Normal-vs-Female |
7.346800E-01 |
| Male-vs-Female |
2.477200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.158800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.303200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.361200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.797000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.574400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.677400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.108600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.629570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.189600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.424000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.657230E-01 |
| Normal-vs-Grade 2 |
1.413960E-01 |
| Normal-vs-Grade 3 |
9.130800E-01 |
| Normal-vs-Grade 4 |
2.269800E-01 |
| Grade 1-vs-Grade 2 |
5.594000E-01 |
| Grade 1-vs-Grade 3 |
3.868000E-01 |
| Grade 1-vs-Grade 4 |
6.704200E-02 |
| Grade 2-vs-Grade 3 |
1.313190E-01 |
| Grade 2-vs-Grade 4 |
3.325700E-02 |
| Grade 3-vs-Grade 4 |
2.488200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.002200E-04 |
| Normal-vs-ccB subtype |
6.516500E-03 |
| ccA subtype-vs-ccB subtype |
1.06900044372082E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.624600E-01 |
| Normal-vs-N1 |
2.864600E-01 |
| N0-vs-N1 |
3.844400E-01 |
|
|
